Acquisition Opportunity Recent acquisition by Seal Shield creates a potential cross-sell and integration path for Vioguard’s UV-C keyboard and device sanitization solutions with Seal Shield’s broader hygienic medical-grade device portfolio.

Publicity Momentum FDA approval for UV sanitization systems and ongoing press coverage provide credibility and talking points to approach healthcare facilities, universities, and corporate environments prioritizing infection control.

Healthcare Focus Vioguard’s UV-C disinfecting technology aligns with hospitals, clinics, and long-term care providers seeking rapid, contactless sanitization, suggesting target markets and procurement channels within medical facilities.

Low Headcount, Niche With a small team and modest revenue, Vioguard presents a partnering opportunity for channel distributors, systems integrators, or OEM collaborations to scale sales through established networks.

Tech & Compliance Advantage Patented UV-C dosimetry and FDA attention position Vioguard for customers requiring verifiable sterilization levels, enabling value propositions around compliance, auditability, and product quality in medical environments.